These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11015632)

  • 1. Prophylactic treatment of depression induced by interferon-alpha.
    Hauser P; Soler R; Reed S; Kane R; Gulati M; Khosla J; Kling MA; Valentine AD; Meyers CA
    Psychosomatics; 2000; 41(5):439-41. PubMed ID: 11015632
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha.
    Schaefer M; Horn M; Schmidt F; Schmid-Wendtner MH; Volkenandt M; Ackenheil M; Mueller N; Schwarz MJ
    Brain Behav Immun; 2004 Nov; 18(6):555-62. PubMed ID: 15331126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychiatric side effects during adjuvant therapy with interferon-alphain patients with malignant melanoma. Clinical evaluation as well as diagnostic and therapeutic possibilities].
    Schäfer M; Messer T; Wegner U; Schmid-Wendtner MH; Volkenandt M
    Hautarzt; 1999 Sep; 50(9):654-8. PubMed ID: 10501682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant interferon in high-risk melanoma: end of the era?
    Janku F; Kurzrock R
    J Clin Oncol; 2010 Jan; 28(2):e15-6; author reply e17-8. PubMed ID: 19949007
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis.
    Sarkar S; Schaefer M
    Psychosomatics; 2014; 55(3):221-34. PubMed ID: 24012293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in hospitalized patients with malignant melanoma treated with interferon-alpha-2b: primary to induced disorders.
    Navinés R; Gómez-Gil E; Puig S; Baeza I; De Pablo J; Martín-Santos R
    Eur J Dermatol; 2009; 19(6):611-5. PubMed ID: 19709980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.
    Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1091-9. PubMed ID: 12030950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanoma.
    Mohr P; Hauschild A; Trefzer U; Weichenthal M
    J Clin Oncol; 2009 Aug; 27(24):e70; author reply e71. PubMed ID: 19620476
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychotic depression occurring after stopping interferon-alpha.
    Prior TI; Chue PS
    J Clin Psychopharmacol; 1999 Aug; 19(4):385-6. PubMed ID: 10440474
    [No Abstract]   [Full Text] [Related]  

  • 10. Sublingually administered fluoxetine for major depression in medically compromised patients.
    Pakyurek M; Pasol E
    Am J Psychiatry; 1999 Nov; 156(11):1833-4. PubMed ID: 10553754
    [No Abstract]   [Full Text] [Related]  

  • 11. Sertraline treatment of interferon-alfa-induced depressive disorder.
    Schramm TM; Lawford BR; Macdonald GA; Cooksley WG
    Med J Aust; 2000 Oct; 173(7):359-61. PubMed ID: 11062791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
    Capuron L; Ravaud A; Miller AH; Dantzer R
    Brain Behav Immun; 2004 May; 18(3):205-13. PubMed ID: 15050647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin-norepinephrine reuptake inhibitor desvenlafaxine for the treatment of interferon alfa-associated depression in patients with hepatitis C.
    Fábregas B; Moura A; Ávila R; Carmo R; Teixeira AL
    Braz J Psychiatry; 2014; 36(2):183. PubMed ID: 24839091
    [No Abstract]   [Full Text] [Related]  

  • 14. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.
    Heinze S; Egberts F; Rötzer S; Volkenandt M; Tilgen W; Linse R; Boettjer J; Vogt T; Spieth K; Eigentler T; Brockmeyer NH; Hinzpeter A; Hauschild A; Schaefer M
    J Immunother; 2010 Jan; 33(1):106-14. PubMed ID: 19952950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated.
    Bannink M; Kruit WH; Van Gool AR; Sleijfer S; van der Holt B; Eggermont AM; Stoter G; Hengeveld MW
    Psychosomatics; 2008; 49(1):56-63. PubMed ID: 18212177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.
    Capuron L; Raison CL; Musselman DL; Lawson DH; Nemeroff CB; Miller AH
    Am J Psychiatry; 2003 Jul; 160(7):1342-5. PubMed ID: 12832253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine and norfluoxetine.
    Mattes JA
    Am J Psychiatry; 1998 Nov; 155(11):1637. PubMed ID: 9812147
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis.
    Ehret M; Sobieraj DM
    Int J Clin Pract; 2014 Feb; 68(2):255-61. PubMed ID: 24372654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine for the prevention of depression induced by high-dose interferon alfa.
    Musselman DL; Lawson DH; Gumnick JF; Manatunga AK; Penna S; Goodkin RS; Greiner K; Nemeroff CB; Miller AH
    N Engl J Med; 2001 Mar; 344(13):961-6. PubMed ID: 11274622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grand mal seizure induced by interferon-alpha-2b.
    Kors C; Milling A; Hofmann M; Sterry W; Trefzer U
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):473-4. PubMed ID: 16643159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.